IS
Insider buying
Investment Gmbh Salvia bought $6M of BBTX stock
Investment Gmbh Salvia, 10% owner of Bambusa Therapeutics, Inc. (BBTX), bought 375,000 shares of BBTX stock worth $6M, per an SEC Form 4 filed Nov 2, 2026.
It was an open-market purchase.
The trade was reported on Nov 2, 2026.
- Traded
- Nov 2, 2026
- Disclosed
- Nov 2, 2026
- Filing delay
- 0 days
- Role
- 10% owner
- Source
- SEC Form 4
More BBTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.